0001921094-23-000739.txt : 20231005
0001921094-23-000739.hdr.sgml : 20231005
20231005163126
ACCESSION NUMBER: 0001921094-23-000739
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231005
DATE AS OF CHANGE: 20231005
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 231311739
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cole Douglas G.
CENTRAL INDEX KEY: 0001486373
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
144
1
primary_doc.xml
144
0001486373
XXXXXXXX
LIVE
0001714899
Denali Therapeutics Inc.
001-38311
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
(650) 866-8548
Cole Douglas G.
Former Affiliate
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
11313
231751.00
137422131
10/05/2023
NASDAQ
Common
06/01/2021
Restricted Stock Lapse
Denali Therapeutics Inc.
N
3253
06/01/2021
Equity Compensation
Common
06/02/2022
Restricted Stock Lapse
Denali Therapeutics Inc.
N
2074
06/02/2022
Equity Compensation
Common
06/02/2023
Restricted Stock Lapse
Denali Therapeutics Inc.
N
5986
06/02/2023
Equity Compensation
Y
10/05/2023
Douglas G. Cole